Back to Search
Start Over
Impact of Serial B-Type Natriuretic Peptide Changes for Predicting Outcome in Asymptomatic Patients With Aortic Stenosis
- Source :
- Canadian Journal of Cardiology, Canadian Journal of Cardiology, Elsevier, 2016, 32 (2), pp.183-189. ⟨10.1016/j.cjca.2015.06.007⟩
- Publication Year :
- 2015
-
Abstract
- Background: The aim of this study was to determine the impact on the outcome of serial B-type natriuretic peptide (BNP) changes during follow-up in asymptomatic patients with >= moderate aortic stenosis (AS) and preserved left ventricular ejection fraction. Methods: We prospectively screened 69 patients who underwent comprehensive transthoracic echocardiography, BNP level measurement at baseline and after every 6 or 12 months. Annualized BNP changes were calculated as the difference between the last and baseline BNP measurements divided by the duration of follow-up. The primary endpoint was the occurrence of symptoms, aortic valve replacement, or cardiovascular death. Results: During a follow-up of 30 +/- 19 months, 43 patients experienced a cardiac event. These patients were significantly older (73 +/- 9 vs 65 +/- 16 years; P = 0.010), had more often dyslipidemia (79% vs 42%; P = 0.038), more severe AS (peak velocity: 3.9 +/- 0.6 vs 3.5 +/- 0.6 m/s; P = 0.002), larger indexed left atrial area (10.2 +/- 2.5 vs 8.7 +/- 1.9 cm(2)/m(2); P = 0.006), and a higher increase in annualized BNP (+90 +/- 155 vs +7 +/- 49 pg/mL/y; P = 0.010). Patients with higher annualized BNP changes (> 20 pg/mL/y) had a significantly lower cardiac event-free survival (1 year: 63 +/- 8% vs 97 +/- 3%; 3 years: 31 +/- 8% vs 68 +/- 8%; P < 0.001). Using the multivariate Cox proportional hazards model, higher annualized BNP changes were significantly associated with increased risk of cardiac events (hazard ratio: 2.73, 95% confidence interval: 1.27-5.86; P = 0.010) after adjustment for age, dyslipidemia, and echocardiographic parameters. Conclusions: In asymptomatic patients with AS and preserved left ventricular ejection fraction, the use of serial BNP changes may help to anticipate development of class I indication for aortic valve replacement.
- Subjects :
- Male
medicine.medical_specialty
Time Factors
medicine.drug_class
030204 cardiovascular system & hematology
Doppler echocardiography
Asymptomatic
Risk Assessment
Severity of Illness Index
Disease-Free Survival
Ventricular Function, Left
03 medical and health sciences
0302 clinical medicine
Aortic valve replacement
Internal medicine
Natriuretic Peptide, Brain
Natriuretic peptide
Medicine
Humans
030212 general & internal medicine
Prospective Studies
Aged
Ejection fraction
medicine.diagnostic_test
business.industry
Stroke Volume
Stroke volume
Aortic Valve Stenosis
medicine.disease
Prognosis
Echocardiography, Doppler
3. Good health
Stenosis
[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie
Aortic valve stenosis
Asymptomatic Diseases
Cardiology
cardiovascular system
Disease Progression
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
Female
medicine.symptom
Cardiology and Cardiovascular Medicine
business
Biomarkers
Follow-Up Studies
Subjects
Details
- ISSN :
- 19167075 and 0828282X
- Volume :
- 32
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- The Canadian journal of cardiology
- Accession number :
- edsair.doi.dedup.....4dc385b9225c02040cdbd2a546e59676